SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters

B.1.617 is becoming a dominant Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) lineage worldwide with many sublineages, of which B.1.617.2 is designated as a variant of concern. The pathogenicity of B.1.617.2 (Delta) and B.1.617.3 lineage of SARS-CoV-2 was evaluated and compared with th...

Full description

Bibliographic Details
Main Authors: Sreelekshmy Mohandas, Pragya Dhruv Yadav, Anita Shete, Dimpal Nyayanit, Gajanan Sapkal, Kavita Lole, Nivedita Gupta
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/9/1773
_version_ 1827681062863503360
author Sreelekshmy Mohandas
Pragya Dhruv Yadav
Anita Shete
Dimpal Nyayanit
Gajanan Sapkal
Kavita Lole
Nivedita Gupta
author_facet Sreelekshmy Mohandas
Pragya Dhruv Yadav
Anita Shete
Dimpal Nyayanit
Gajanan Sapkal
Kavita Lole
Nivedita Gupta
author_sort Sreelekshmy Mohandas
collection DOAJ
description B.1.617 is becoming a dominant Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) lineage worldwide with many sublineages, of which B.1.617.2 is designated as a variant of concern. The pathogenicity of B.1.617.2 (Delta) and B.1.617.3 lineage of SARS-CoV-2 was evaluated and compared with that of B.1, an early virus isolate with D614G mutation in a Syrian hamster model. Viral load, antibody response, and lung disease were studied. There was no significant difference in the virus shedding pattern among these variants. High levels of SARS-CoV-2 sub genomic RNA were detected in the respiratory tract of hamsters infected with the Delta variant for 14 days, which warrants further transmission studies. The Delta variant induced lung disease of moderate severity in about 40% of infected animals, which supports the attributed disease severity of the variant. Cross neutralizing antibodies were detected in animals infected with B.1, Delta, and B.1.617.3 variant, but neutralizing capacity was significantly lower with B.1.351 (Beta variant).
first_indexed 2024-03-10T07:09:01Z
format Article
id doaj.art-c650ca2143784cfd82492ff494d28348
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T07:09:01Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-c650ca2143784cfd82492ff494d283482023-11-22T15:37:45ZengMDPI AGViruses1999-49152021-09-01139177310.3390/v13091773SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian HamstersSreelekshmy Mohandas0Pragya Dhruv Yadav1Anita Shete2Dimpal Nyayanit3Gajanan Sapkal4Kavita Lole5Nivedita Gupta6Indian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi 110029, IndiaB.1.617 is becoming a dominant Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) lineage worldwide with many sublineages, of which B.1.617.2 is designated as a variant of concern. The pathogenicity of B.1.617.2 (Delta) and B.1.617.3 lineage of SARS-CoV-2 was evaluated and compared with that of B.1, an early virus isolate with D614G mutation in a Syrian hamster model. Viral load, antibody response, and lung disease were studied. There was no significant difference in the virus shedding pattern among these variants. High levels of SARS-CoV-2 sub genomic RNA were detected in the respiratory tract of hamsters infected with the Delta variant for 14 days, which warrants further transmission studies. The Delta variant induced lung disease of moderate severity in about 40% of infected animals, which supports the attributed disease severity of the variant. Cross neutralizing antibodies were detected in animals infected with B.1, Delta, and B.1.617.3 variant, but neutralizing capacity was significantly lower with B.1.351 (Beta variant).https://www.mdpi.com/1999-4915/13/9/1773SARS-CoV-2Delta variantB.1.617.2B.1.617.3Syrian hamsterpathogenicity
spellingShingle Sreelekshmy Mohandas
Pragya Dhruv Yadav
Anita Shete
Dimpal Nyayanit
Gajanan Sapkal
Kavita Lole
Nivedita Gupta
SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
Viruses
SARS-CoV-2
Delta variant
B.1.617.2
B.1.617.3
Syrian hamster
pathogenicity
title SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
title_full SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
title_fullStr SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
title_full_unstemmed SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
title_short SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
title_sort sars cov 2 delta variant pathogenesis and host response in syrian hamsters
topic SARS-CoV-2
Delta variant
B.1.617.2
B.1.617.3
Syrian hamster
pathogenicity
url https://www.mdpi.com/1999-4915/13/9/1773
work_keys_str_mv AT sreelekshmymohandas sarscov2deltavariantpathogenesisandhostresponseinsyrianhamsters
AT pragyadhruvyadav sarscov2deltavariantpathogenesisandhostresponseinsyrianhamsters
AT anitashete sarscov2deltavariantpathogenesisandhostresponseinsyrianhamsters
AT dimpalnyayanit sarscov2deltavariantpathogenesisandhostresponseinsyrianhamsters
AT gajanansapkal sarscov2deltavariantpathogenesisandhostresponseinsyrianhamsters
AT kavitalole sarscov2deltavariantpathogenesisandhostresponseinsyrianhamsters
AT niveditagupta sarscov2deltavariantpathogenesisandhostresponseinsyrianhamsters